205 related articles for article (PubMed ID: 32582959)
1. MicroRNA‑103 modulates tumor progression by targeting KLF7 in non‑small cell lung cancer.
Li K; Yuan C
Int J Mol Med; 2020 Sep; 46(3):1013-1028. PubMed ID: 32582959
[TBL] [Abstract][Full Text] [Related]
2. STAT3-induced long noncoding RNA LINC00668 promotes migration and invasion of non-small cell lung cancer via the miR-193a/KLF7 axis.
An YX; Shang YJ; Xu ZW; Zhang QC; Wang Z; Xuan WX; Zhang XJ
Biomed Pharmacother; 2019 Aug; 116():109023. PubMed ID: 31150989
[TBL] [Abstract][Full Text] [Related]
3. miR-185 Inhibits the Proliferation and Invasion of Non-Small Cell Lung Cancer by Targeting KLF7.
Zhao L; Zhang Y; Liu J; Yin W; Jin D; Wang D; Zhang W
Oncol Res; 2019 Sep; 27(9):1015-1023. PubMed ID: 29716672
[TBL] [Abstract][Full Text] [Related]
4. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
5. MicroRNA-625 inhibits the progression of non‑small cell lung cancer by directly targeting HOXB5 and deactivating the Wnt/β-catenin pathway.
Tan X; Jiang L; Wu X; Feng W; Lin Q
Int J Mol Med; 2019 Jul; 44(1):346-356. PubMed ID: 31115501
[TBL] [Abstract][Full Text] [Related]
6. miR-200b/c targets the expression of RhoE and inhibits the proliferation and invasion of non-small cell lung cancer cells.
Tang Q; Li M; Chen L; Bi F; Xia H
Int J Oncol; 2018 Oct; 53(4):1732-1742. PubMed ID: 30066855
[TBL] [Abstract][Full Text] [Related]
7. Circ_0067934 promotes non-small cell lung cancer development by regulating miR-1182/KLF8 axis and activating Wnt/β-catenin pathway.
Zhao M; Ma W; Ma C
Biomed Pharmacother; 2020 Sep; 129():110461. PubMed ID: 32768951
[TBL] [Abstract][Full Text] [Related]
8. Silencing of
Zhang P; Li Z; Yang G
Int J Mol Med; 2021 Dec; 48(6):. PubMed ID: 34713300
[TBL] [Abstract][Full Text] [Related]
9. miR‑454‑3p inhibits non‑small cell lung cancer cell proliferation and metastasis by targeting TGFB2.
Liao H; Liang Y; Kang L; Xiao Y; Yu T; Wan R
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760169
[TBL] [Abstract][Full Text] [Related]
10. ΜicroRNA‑421 promotes the progression of non‑small cell lung cancer by targeting HOPX and regulating the Wnt/β‑catenin signaling pathway.
Liang H; Wang C; Gao K; Li J; Jia R
Mol Med Rep; 2019 Jul; 20(1):151-161. PubMed ID: 31115507
[TBL] [Abstract][Full Text] [Related]
11. IL‑21/IL‑21R inhibit tumor growth and invasion in non‑small cell lung cancer cells via suppressing Wnt/β‑catenin signaling and PD‑L1 expression.
Xue D; Yang P; Wei Q; Li X; Lin L; Lin T
Int J Mol Med; 2019 Nov; 44(5):1697-1706. PubMed ID: 31573051
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA‑92a promotes non‑small cell lung cancer cell growth by targeting tumor suppressor gene FBXW7.
Ni D; Teng J; Cheng Y; Zhu Z; Zhuang B; Yang Z
Mol Med Rep; 2020 Oct; 22(4):2817-2825. PubMed ID: 32945381
[TBL] [Abstract][Full Text] [Related]
13. Propofol suppresses the progression of non‑small cell lung cancer via downregulation of the miR‑21‑5p/MAPK10 axis.
Wu X; Li X; Xu G
Oncol Rep; 2020 Aug; 44(2):487-498. PubMed ID: 32468043
[TBL] [Abstract][Full Text] [Related]
14. Long non‑coding RNA SNHG3 promotes the development of non‑small cell lung cancer via the miR‑1343‑3p/NFIX pathway.
Zhao L; Song X; Guo Y; Ding N; Wang T; Huang L
Int J Mol Med; 2021 Aug; 48(2):. PubMed ID: 34132359
[TBL] [Abstract][Full Text] [Related]
15. NORAD regulates epithelial‑mesenchymal transition of non‑small cell lung cancer cells via miR‑422a.
Chen Z; Che Q; Xie C
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300080
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA‑103 regulates tumorigenesis in colorectal cancer by targeting ZO‑1.
Ke J; Shao W; Jiang Y; Xu J; Li F; Qin J
Mol Med Rep; 2018 Jan; 17(1):783-788. PubMed ID: 29115525
[TBL] [Abstract][Full Text] [Related]
17. miR‑505 inhibits cell growth and EMT by targeting MAP3K3 through the AKT‑NFκB pathway in NSCLC cells.
Tang H; Lv W; Sun W; Bi Q; Hao Y
Int J Mol Med; 2019 Mar; 43(3):1203-1216. PubMed ID: 30628663
[TBL] [Abstract][Full Text] [Related]
18. Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro.
Gao LM; Zheng Y; Wang P; Zheng L; Zhang WL; Di Y; Chen LL; Yin XB; Tian Q; Shi SS; Xu SF
Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L918-L933. PubMed ID: 30628487
[TBL] [Abstract][Full Text] [Related]
19. MiR-182 inhibits the epithelial to mesenchymal transition and metastasis of lung cancer cells by targeting the Met gene.
Li Y; Zhang H; Li Y; Zhao C; Fan Y; Liu J; Li X; Liu H; Chen J
Mol Carcinog; 2018 Jan; 57(1):125-136. PubMed ID: 28940757
[TBL] [Abstract][Full Text] [Related]
20. miR-25 enhances cell migration and invasion in non-small-cell lung cancer cells via ERK signaling pathway by inhibiting KLF4.
Ding X; Zhong T; Jiang L; Huang J; Xia Y; Hu R
Mol Med Rep; 2018 May; 17(5):7005-7016. PubMed ID: 29568911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
